Boxer Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.4M Buy
5,150,000
+1,650,000
+47% +$7.13M 2.21% 12
2026
Q1
$13.5M Buy
3,500,000
+2,125,000
+155% +$8.72M 1.78% 16
2025
Q4
$5.75M Buy
1,375,000
+525,000
+62% +$2.03M 1.26% 23
2025
Q3
$2.8M Buy
+850,000
New +$2.4M 0.89% 22

Other funds holding PGEN

Boxer Capital Management's PGEN Position: Q2 2026 in Review

Boxer Capital Management increased its Precigen (PGEN) stake by 47% in Q2 2026, buying an estimated $7.13M and bringing the position to 5,150,000 shares worth $29.4M. The position accounts for 2.21% of the portfolio, ranked #12.

Boxer Capital Management first reported a position in PGEN in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Boxer Capital Management held 5,150,000 shares of Precigen worth $29.4M as of Q2 2026.
  • Boxer Capital Management bought 1,650,000 Precigen shares in Q2 2026, an estimated $7.13M.
  • Precigen made up 2.21% of Boxer Capital Management's portfolio in Q2 2026, its #12 holding.
  • Boxer Capital Management first reported a position in Precigen in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.